Tumor progression and recurrence after direct-acting antiviral therapy for hepatitis C in patients with previously treated or active hepatocellular carcinoma

被引：0
|
作者：
Wong, M. Y. W. [1 ]
Mccaughan, G. W. [1 ]
Mason, S. [1 ]
Moore, B. [1 ]
Koorey, D. J. [1 ]
Bowen, D. G. [1 ]
Strasser, S. I. [1 ]
机构：
[1] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [31] Rapidly growing hepatocellular carcinoma recurrence during direct-acting antiviral treatment for chronic hepatitis C
    Yamashita N.
    Tanimoto H.
    Shimoda S.
    Komori A.
    Nomura H.
    Clinical Journal of Gastroenterology, 2018, 11 (6) : 497 - 500
  • [32] Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?
    Jain, Ashokkumar
    Miller, Danielle
    Schreibman, Ian
    Riley, Thomas R., III
    Krok, Karen L.
    Dohi, Takehiko
    Sharma, Rajeev
    Kadry, Zakiyah
    HEPATOLOGY INTERNATIONAL, 2019, 13 (02) : 190 - 198
  • [33] Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs
    Yang, Caiyun
    Lv, Fengxiang
    Yang, Jiaqi
    Ding, Dawei
    Cui, Lina
    Han, Ying
    ANNALS OF HEPATOLOGY, 2025, 30 (02)
  • [34] Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C
    Kawaguchi T.
    Ide T.
    Koga H.
    Kondo R.
    Miyajima I.
    Arinaga-Hino T.
    Kuwahara R.
    Amano K.
    Niizeki T.
    Nakano M.
    Kuromatsu R.
    Torimura T.
    Clinical Journal of Gastroenterology, 2018, 11 (1) : 69 - 74
  • [35] Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus
    Mawatari, Seiichi
    Kumagai, Kotaro
    Oda, Kohei
    Tabu, Kazuaki
    Ijuin, Sho
    Fujisaki, Kunio
    Tashima, Shuzo
    Inada, Yukiko
    Uto, Hirofumi
    Saisyoji, Akiko
    Hiramine, Yasunari
    Hashiguchi, Masafumi
    Tamai, Tsutomu
    Hori, Takeshi
    Taniyama, Ohki
    Toyodome, Ai
    Sakae, Haruka
    Kure, Takeshi
    Sakurai, Kazuhiro
    Moriuchi, Akihiro
    Kanmura, Shuji
    Ido, Akio
    PLOS ONE, 2022, 17 (01):
  • [36] Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents
    Mendizabal, Manuel
    Pinero, Federico
    Ridruejo, Ezequiel
    Wolff, Fernando Herz
    Anders, Margarita
    Reggiardo, Virginia
    Ameigeiras, Beatriz
    Palazzo, Ana
    Alonso, Cristina
    Schinoni, Maria Isabel
    Zuain, Maria Grazia Videla
    Tanno, Federico
    Figueroa, Sebastian
    Santos, Luisa
    Peralta, Mirta
    Soza, Alejandro
    Vistarini, Cecilia
    Adrover, Raul
    Fernandez, Nora
    Perez, Daniela
    Hernandez, Nelia
    Estepo, Claudio
    Bruno, Andres
    Descalzi, Valeria
    Sixto, Marcela
    Borzi, Silvia
    Cocozzella, Daniel
    Zerega, Alina
    de Araujo, Alexandre
    Varon, Adriana
    Rubinstein, Fernando
    Cheinquer, Hugo
    Silva, Marcelo
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (11) : 2554 - +
  • [37] The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma
    Chen, Yu-Syuan
    Huang, Kuo-Hsuan
    Wang, Pei-Ming
    Chuang, Ching-Hui
    Yong, Chee-Chien
    Liu, Yueh-Wei
    Huang, Pao-Yuan
    Yao, Chih-Chien
    Lin, Yen-Po
    Tsai, Ming-Chao
    MEDICINA-LITHUANIA, 2022, 58 (02):
  • [38] Direct-acting antiviral therapy reduces the recurrence risk in patients with hepatitis C virus-related early stage hepatocellular carcinoma after curative resection
    Huang, Kuo-Hsuan
    Chen, Chien-Hung
    Hung, Chao-Hung
    Wang, Jing-Houng
    Tsai, Tsung Ming-Chao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 259 - 260
  • [39] Interferon-free direct-acting antiviral therapy decreases the rate of hepatocellular carcinoma recurrence in patients with chronic hepatitis C and advanced fibrosis
    Virlogeux, V.
    Pradat, P.
    Hartig-Lavie, K.
    Bailly, F.
    Maynard, M.
    Ouziel, G.
    Poinsot, D.
    Lebosse, F.
    Ecochard, M.
    Radenne, S.
    Benmakhlouf, S.
    Koffi, J.
    Lack, P.
    Scholtes, C.
    Uhres, A. -C.
    Ducerf, C.
    Mabrut, J. -Y.
    Rode, A.
    Levrero, M.
    Combet, C.
    Merle, P.
    Zoulim, F.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S745 - S745
  • [40] De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents
    Kuftinec, Gabriela
    Loehfelm, Thomas
    Corwin, Michael
    Durbin-Johnson, Blythe
    Candido, MarieChristi
    Hluhanich, Rebecca
    Sarkar, Souvik
    HEPATIC ONCOLOGY, 2018, 5 (01)
12345